51.3
Context Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
37.9
FY23:
16.0
FY24:
97.9
FY25:
68.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.05
FY22:
0.11
FY23:
0.02
FY24:
0.23
FY25:
0.14
Total assets
Change from FY21 to FY25
millions USD
FY21:
51.3
FY22:
38.0
FY23:
16.1
FY24:
98.1
FY25:
68.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.03
FY22:
3.21
FY23:
4.19
FY24:
2.75
FY25:
8.02
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0.11
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
48.3
FY22:
34.8
FY23:
11.9
FY24:
95.3
FY25:
60.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
51.3
FY22:
38.0
FY23:
16.1
FY24:
98.1
FY25:
68.5
All amounts in millions USD